FDA Reorganization Will Not Include John Taylor, Hamburg’s Great Actor

Taylor’s exit from the agency comes as commissioner awaits recommendations from a panel of senior agency officials on how to ensure the centers support Office of Regulatory Affairs’ activities without duplication.